| Literature DB >> 21647552 |
Balazs Sarkadi1, Gerald Schatten.
Abstract
In April 2011, an international advanced course and workshop entitled "Frontiers in Human Pluripotent Stem Cells" and an International Congress on Fertility and Genetics ( http://www.fertigen.com.jo/ConferenceDetails.aspx ) was held in Amman Jordan hosted by the Jordanian Society of Fertility and Genetics under the auspices of the International Cell Research Organization (ICRO), a UNESCO associated NGO. The Congress President Dr. Zaid Kilani, with Dr. Abdel Latif Abu Khadra, President of the Jordanian society for Fertility and Genetics, Dr. Rana Dajani of the Hashemite University of Jordan, and their Organizing Committee proved to be an excellent organizers and dedicated physician-scientists and, focusing on fertility, genetics and stem cells in a wide range of advanced therapeutic applications. Brilliant course participants included trainees, scientists and clinicians from the Greater Middle East. The lectures and practical sessions, presented by internationally acknowledged scientists, included overviews of recent achievements in pluripotent stem cell research, emphasizing the role of both the embryonic (ES) and induced pluripotent stem (iPS) cells. A major emphasis was placed on the clinical achievements in germ cell and umbilical cord stem cell transplantation issues, and on the potential of fast and successful prenatal and pre-implantation molecular genetics diagnostics. The organization of the stem cell course in the Holy Land especially emphasized that issues of "eternal life" and "rejuvenation" are already at hand--at least in the pluripotent stem cell research field. In the lively atmosphere of the course about 60 participants had heated discussions on the possibility and ethics of advanced prenatal diagnostics, and on regulatory issues reflecting the need of separation of clinically effective versus unapproved, unwarranted stem cell treatments. An open discussion of many ethical issues, reflecting profound differences in religion and medical tradition in the different countries, made this course exceptionally interesting for both teachers and trainees.Entities:
Mesh:
Year: 2012 PMID: 21647552 PMCID: PMC3285749 DOI: 10.1007/s12015-011-9277-z
Source DB: PubMed Journal: Stem Cell Rev Rep ISSN: 2629-3277 Impact factor: 5.739
Fig. 1Opening Session of the JORDIAN SOCIETY FOR FERTILITY AND GENETICS Congress and Commencement for the Stem Cell Workshop. High Royal Highness Princess Basma Bint Talal of Jordan (Center). Dr. Zaid Kilani is directly to her right and the authors (B.S.; 3rd right and G.S.; her left) are also in this figure together with many of the speakers
| THURSDAY | |||
| I | REPRODUCTIVE SURGERY | ||
| TITLE | SPEAKER | COUNTRY | |
| 9:00–9:30 | Endometrioma and IVF: to touch or not to touch | Juan Garcia-Velasco | Spain |
| 9:30–10:00 | The long term effects of electrocautery of the ovaries in PCOS | Fulco Van Der Veen | Netherland |
| 10:00–10:30 | Embryo transfer can we improve it? | Rene Frydman | France |
| 10:30–11:00 | Coffee break | ||
| II | KEYNOTE LECTURES | ||
| TITLE | SPEAKER | COUNTRY | |
| 11:00–11:45 | Progesterone induced blood flow in improving pregnancy outcome | Salim Daya | Canada |
| 11:45–12:30 | Modern ART in today's society | Jurgis Gedis Grudzinskas | UK |
| 12:30–2:00 | Lunch break session: Hot controversial Topics in ART | ||
| III | MALE INFERTILITY | ||
| TITLE | SPEAKER | COUNTRY | |
| 2:00–2:30 | What's new with diagnosing sperm defects? | Christopher Barratt | UK |
| 2:30–3:00 | Non-obstructive azoospermia:Evolution of treatment | Peter Schlegel | USA |
| 3:00–3:30 | Repeated micro-dissection TESE: is there a limit? | Abdel Latif Abu Khadra | Jordan |
| 3:30–4:00 | Coffee break | ||
| IV | REPRODUCTIVE GENETICS | ||
| TITLE | SPEAKER | COUNTRY | |
| 4:00–4:30 | Clinical aspects of globozoospermia | Christopher Barratt | UK |
| 4:30–5:00 | Genetics of infertility : how to clone human genes solely involved in infertility phenotype | Stephane Vivilli | France |
| 5:00–5:30 | What have stem cells taught us about early human embryology | Peter Braude | UK |
| FRIDAY | |||
| V | INFERTILITY MANAGEMENT | ||
| TITLE | SPEAKER | COUNTRY | |
| 9:00–9:30 | The pros and cons of IUI | Willem Ombelet | Belgium |
| 9:30–10:00 | GnRH antagonists are safer than agonists | Hesham Al Inany | Egypt |
| 10:00–10:30 | OHSS risk reduction/prevention in ART | Peter Humaidan | Denmark |
| 10:30–11:00 | Coffee break | ||
| VI | KEYNOTE LECTURES | ||
| TITLE | SPEAKER | COUNTRY | |
| 11:00–11:45 | Managing male infertility in the 21st century: Optimizing diagnostic and treatments by mechanistic understandings and avoiding intractable male infertility | Gerald Schatten | USA |
| 11:45–12:30 | Preimplantation Genetics in 2011: The Promise and The Controversies | Mark Hughes | USA |
| 12:30–2:30 | Lunch break | ||
| VII | IVF LAB | ||
| TITLE | SPEAKER | COUNTRY | |
| 2:30–3:00 | New developments on sperm selection for ICSI | Willem Ombelet | Belgium |
| 3:00–3:30 | Objective markers of oocyte and embryo viability | Marcos Meseguer | Spain |
| 3:30–4:00 | Impact of lifestyle factors and antioxidative treatment on sperm analysis results (WHO AND MSOME criteria) | Johannes Wogatzky | Austria |
| 4:00–4:30 | Coffee break | ||
| VIII | CLINICAL ART | ||
| TITLE | SPEAKER | COUNTRY | |
| 4:30–5:00 | Evidenced based management of poor ovarian response | Stratis Kolibianakis | Greece |
| 5:00–5:30 | “Single Embryo Transfer: The way ahead?” | Peter Brinsden | UK |
| 5:30–6:00 | closing remarks | Peter Brinsden | UK |